Abstract
The aims of these open studies were to assess human lymphoblastoid interferon-α (Wellferon, Wellcome Foundation Limited) in the treatment of severe, persistent warts and to (a) evaluate the relative merits of the intralesional, intramuscular and dermojet routes of administration and (b) establish a safe, effective and patient-acceptable treatment regime which could subsequently be used in fully controlled studies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gibson, J.R., Salisbury, J., Harvey, S.G., Marks, P. (1988). Interferon — Therapy/Experimental Results. In: Orfanos, C.E., Stadler, R., Gollnick, H. (eds) Dermatology in Five Continents. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83360-1_121
Download citation
DOI: https://doi.org/10.1007/978-3-642-83360-1_121
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83362-5
Online ISBN: 978-3-642-83360-1
eBook Packages: Springer Book Archive